as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High
2.37%
Downside
1.38%
Upside
52 Week's Low
52 Week's High
59.88%
Downside
5.28%
Upside
Check Sight Sciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$266.0M
EPS (TTM)
-0.9846
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.5
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-48.1M
Revenue (TTM)
76.3M
Profit Margin
-64.23%
Return On Equity TTM
-57.10%
Track how Sight Sciences Inc P/E has moved over time to understand its valuation trends.
Sight Sciences Inc in the last 5 years
Lowest (-6.69x)
March 31, 2023
Today (-6.50x)
November 1, 2025
Industry (-0.81x)
November 1, 2025
Highest (-2.71x)
December 31, 2023
Today’s Price to Earnings Ratio: -6.50x
Compare market cap, revenue, PE, and other key metrics of Sight Sciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $266.0M | NA | -6.5 | -64.23% | |
| BUY | $149.0B | 193.9% | 53.78 | 14.43% | |
| BUY | $141.1B | 76.35% | 48.81 | 12.25% | |
| BUY | $216.8B | 17.61% | 15.68 | 31.88% | |
| BUY | $48.4B | 15.01% | 34.5 | 72.96% |
The Sight Sciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sight Sciences Inc investment value today
Current value as on today
₹1,02,827
Returns
₹2,827
(+2.83%)
Returns from Sight Sciences Inc Stock
Dollar Returns*
₹5,706 (+5.71%)
Based on 12 analysts
50.00%
Buy
50.00%
Hold
0.00%
Sell
Based on 12 analysts, 50% of analysts recommend a 'BUY' rating for Sight Sciences Inc. Average target price of $4.67
Get share price movements and forecasts by analysts on Sight Sciences Inc.
What analysts predicted
-8.35%DOWNSIDE
Target Price
$4.67
Current Price
$5.06
Analyzed by
12 Analysts
Target
$4.67
Sight Sciences Inc target price $4.67, a slight downside of -8.35% compared to current price of $5.06. According to 12 analysts rating.
Search interest for Sight Sciences Inc Stock has increased by 175% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:175% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 09 September
Tue, 09:09 PM
-UnitedHealthcare expands coverage for glaucoma surgeries, effective October 1, 2025, enhancing Sight Sciences' market position.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -14.15M → -11.94M (in $), with an average increase of 18.5% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 17.50M → 19.56M (in $), with an average increase of 10.5% per quarter
Price Rise
![]()
In the last 1 month, SGHT stock has moved up by 51.6%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 15.0% return, outperforming this stock by 51.8%
Against Peers
![]()
In the last 1 year, Edwards Lifesciences Corp. has given 23.6% return, outperforming this stock by 26.1%
| Organisation | Sight Sciences Inc |
| Headquarters | 4040 Campbell Avenue, Menlo Park, CA, United States, 94025 |
| Industry | Healthcare |
| CEO | Mr. Paul Badawi |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Jim Rodberg | VP of Finance & Corporate Controller |
Mr. Paul Badawi | Co-Founder, President, CEO & Director |
Dr. David Badawi M.D. | Co-Founder, CTO & Director |
Ms. Alison Perry Bauerlein | CFO, Principal Financial & Accounting Officer and Treasurer |
Mr. Jeremy B. Hayden J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Brenton Taylor | Executive Vice President of Operations |
Mr. Steve R. Tamayo Jr. | VP and Chief Ethics & Compliance Officer |
Mr. Mark Papini | Senior Vice President of Glaucoma |
Sight Sciences Inc share price today is $5.06 as on at the close of the market. Sight Sciences Inc share today touched a day high of $5.13 and a low of $4.94.
Sight Sciences Inc share touched a 52 week high of $5.33 on and a 52 week low of $2.03 on . Sight Sciences Inc stock price today i.e. is closed at $5.06,which is 5.01% down from its 52 week high and 149.26% up from its 52 week low.
Sight Sciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Sight Sciences Inc (SGHT) shares with as little as ₹88.719 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.19 in Sight Sciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sight Sciences Inc share’s latest price of $5.06 as on November 1, 2025 at 1:29 am IST, you will get 1.9763 shares of Sight Sciences Inc. Learn more about
fractional shares .